163 related articles for article (PubMed ID: 35208821)
21. IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6.
Akkarathamrongsin S; Thong VD; Payungporn S; Poovorawan K; Prapunwattana P; Poovorawan Y; Tangkijvanich P
J Med Virol; 2014 Sep; 86(9):1482-90. PubMed ID: 24782280
[TBL] [Abstract][Full Text] [Related]
22. IFNL4: Notable variants and associated phenotypes
Fang MZ; Jackson SS; O'Brien TR
Gene; 2020 Mar; 730():144289. PubMed ID: 31846709
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C.
Fujino H; Imamura M; Nagaoki Y; Kawakami Y; Abe H; Hayes CN; Kan H; Fukuhara T; Kobayashi T; Masaki K; Ono A; Nakahara T; Honda Y; Naeshiro N; Urabe A; Yokoyama S; Miyaki D; Murakami E; Kawaoka T; Hiraga N; Tsuge M; Hiramatsu A; Hyogo H; Aikata H; Takahashi S; Miki D; Ochi H; Ohishi W; Chayama K;
J Gastroenterol; 2014 Dec; 49(12):1548-56. PubMed ID: 24362944
[TBL] [Abstract][Full Text] [Related]
24. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S
J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
[TBL] [Abstract][Full Text] [Related]
25. IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children.
Samayoa-Reyes G; Jackson C; Ogolla S; Sabourin K; Obajemu A; Dent AE; Prokunina-Olsson L; Rochford R
Malar J; 2021 Apr; 20(1):196. PubMed ID: 33882912
[TBL] [Abstract][Full Text] [Related]
26. Demographics, clinical characteristics, IFNL3- and IFNL4- polymorphisms in a cohort of hepatitis C patients from Puerto Rico.
Morales-Vásquez L; Miranda-Avalo EI; Rodríguez-Medina JR; Quiñones-Badillo Y; Marqués-Lespier J; Muñoz-Acabá J; Pastrana R; Pérez-Cardona CM; Yamamura Y; Torres EA
P R Health Sci J; 2014 Dec; 33(4):177-83. PubMed ID: 25563035
[TBL] [Abstract][Full Text] [Related]
27. IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.
Galmozzi E; Facchetti F; Grossi G; Loglio A; Viganò M; Lunghi G; Colombo M; Lampertico P
Liver Int; 2018 Mar; 38(3):417-423. PubMed ID: 28732143
[TBL] [Abstract][Full Text] [Related]
28.
Minas TZ; Tang W; Smith CJ; Onabajo OO; Obajemu A; Dorsey TH; Jordan SV; Obadi OM; Ryan BM; Prokunina-Olsson L; Loffredo CA; Ambs S
Commun Biol; 2018; 1():191. PubMed ID: 30456312
[TBL] [Abstract][Full Text] [Related]
29. Interferon lambda4 polymorphism is not associated with human papillomavirus infection outcome.
Cannella F; Scagnolari C; Statzu M; Sciandra I; Recine N; d'Ettorre G; Antonelli G; Pierangeli A
Virus Genes; 2018 Apr; 54(2):319-322. PubMed ID: 29243064
[TBL] [Abstract][Full Text] [Related]
30. Interferon Lambda 4 Polymorphism Predicts Sustained Viral Response in Hepatitis C Virus Patients Irrespective of Hepatitis C Virus Genotypes, Ethnicity or Treatment Regimen: Results From a Meta-Analysis.
Wu Q; Wang C; Chen EQ; Tang H; Li ZZ; Lei XZ
Hepat Mon; 2015 Dec; 15(12):e32707. PubMed ID: 26977165
[TBL] [Abstract][Full Text] [Related]
31. Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3.
Peiffer KH; Sommer L; Susser S; Vermehren J; Herrmann E; Döring M; Dietz J; Perner D; Berkowski C; Zeuzem S; Sarrazin C
Hepatology; 2016 Jan; 63(1):63-73. PubMed ID: 26406534
[TBL] [Abstract][Full Text] [Related]
32.
Roy N; Prasad C; Kumar A; Mondol K; Jain K; Yadav R; Jha JK; Nadda N; Acharya SK; Shalimar ; Nayak B
Virusdisease; 2019 Sep; 30(3):344-353. PubMed ID: 31803800
[TBL] [Abstract][Full Text] [Related]
33. Association between
Agwa SHA; Kamel MM; Elghazaly H; Abd Elsamee AM; Hafez H; Girgis SA; Ezz Elarab H; Ebeid FSE; Sayed SM; Sherif L; Matboli M
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34071309
[TBL] [Abstract][Full Text] [Related]
34. IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis.
Eslam M; McLeod D; Kelaeng KS; Mangia A; Berg T; Thabet K; Irving WL; Dore GJ; Sheridan D; Grønbæk H; Abate ML; Hartmann R; Bugianesi E; Spengler U; Rojas A; Booth DR; Weltman M; Mollison L; Cheng W; Riordan S; Mahajan H; Fischer J; Nattermann J; Douglas MW; Liddle C; Powell E; Romero-Gomez M; George J;
Nat Genet; 2017 May; 49(5):795-800. PubMed ID: 28394349
[TBL] [Abstract][Full Text] [Related]
35. Association of Interferon Lambda 3 and 4 Gene SNPs and Their Expression with COVID-19 Disease Severity: A Cross-Sectional Study.
Zahid W; Farooqui N; Zahid N; Ahmed K; Anwar MF; Rizwan-Ul-Hasan S; Hussain AR; Sarría-Santamera A; Abidi SH
Infect Drug Resist; 2023; 16():6619-6628. PubMed ID: 37840831
[TBL] [Abstract][Full Text] [Related]
36. No Association of IFNL4 Genotype With Opportunistic Infections and Cancers Among Men With Human Immunodeficiency Virus 1 Infection.
Fang MZ; Jackson SS; Pfeiffer RM; Kim EY; Chen S; Hussain SK; Jacobson LP; Martinson J; Prokunina-Olsson L; Thio CL; Duggal P; Wolinsky S; O'Brien TR
Clin Infect Dis; 2023 Feb; 76(3):521-527. PubMed ID: 36573283
[TBL] [Abstract][Full Text] [Related]
37. Interferon lambda 4 gene polymorphisms as a predicting tool of response to hepatitis C virus genotype 4 patients treated with Sofosbuvir and Ribavirin.
Sakr AA; Ahmed AE; Abd El-Maksoud MDE; Gamal A; El-Garem H; Ahmed OM
Infect Genet Evol; 2020 Dec; 86():104606. PubMed ID: 33127459
[TBL] [Abstract][Full Text] [Related]
38. The
Zhou H; Møhlenberg M; Terczyńska-Dyla E; Winther KG; Hansen NH; Vad-Nielsen J; Laloli L; Dijkman R; Nielsen AL; Gad HH; Hartmann R
J Virol; 2020 Feb; 94(5):. PubMed ID: 31776283
[TBL] [Abstract][Full Text] [Related]
39. A Knockout IFNL4 Variant Is Associated With Protection From Sexually Transmitted HIV-1 Infection.
Jaimes-Bernal C; Rallón N; Benito JM; Omar M; Gómez-Vidal MA; Márquez FJ; Sánchez-Arcas B; Trujillo M; Royo JL; Saulle I; Biasin M; Rivero-Juárez A; Caruz A
J Infect Dis; 2019 Feb; 219(5):772-776. PubMed ID: 30289470
[TBL] [Abstract][Full Text] [Related]
40. Human herpesvirus 8 infection is associated with prostate cancer among IFNL4-ΔG carriers.
Jenkins FJ; Minas TZ; Tang W; Dorsey TH; Ambs S
Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):338-346. PubMed ID: 35468990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
